Total Payments
$1,917
2024 Payments
$21.00
Companies
18
Transactions
62
Medicare Patients
1,637
Medicare Billing
$118,601
Payment Breakdown by Category
Food & Beverage$1,796 (93.7%)
Education$120.94 (6.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,796 | 59 | 93.7% |
| Education | $120.94 | 3 | 6.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PROCEPT BioRobotics Corporation | $668.80 | 8 | $0 (2018) |
| Astellas Pharma US Inc | $307.07 | 12 | $0 (2020) |
| Boston Scientific Corporation | $175.98 | 5 | $0 (2019) |
| Janssen Biotech, Inc. | $116.92 | 5 | $0 (2019) |
| Endo Pharmaceuticals Inc. | $115.46 | 6 | $0 (2020) |
| AbbVie, Inc. | $92.43 | 4 | $0 (2019) |
| Allergan, Inc. | $87.95 | 4 | $0 (2020) |
| Mallinckrodt Enterprises LLC | $65.30 | 3 | $0 (2019) |
| AUGMENIX, INC. | $57.54 | 1 | $0 (2017) |
| TOLMAR Pharmaceuticals, Inc. | $49.11 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.00 | 1 | PFIZER INC. ($21.00) |
| 2020 | $185.66 | 5 | Astellas Pharma US Inc ($114.56) |
| 2019 | $331.20 | 17 | Astellas Pharma US Inc ($63.62) |
| 2018 | $1,001 | 21 | PROCEPT BioRobotics Corporation ($668.80) |
| 2017 | $378.10 | 18 | Astellas Pharma US Inc ($81.92) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/26/2024 | PFIZER INC. | ORGOVYX (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2020 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 02/20/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: UROLOGY | ||||||
| 02/13/2020 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: UROLOGY | ||||||
| 02/05/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: HYPERHYDROSIS | ||||||
| 01/24/2020 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: UROLOGY | ||||||
| 10/10/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: UROLOGY | ||||||
| 09/19/2019 | Boston Scientific Corporation | GENERAL KIDNEY STONE DISEASE (Device) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: KIDNEY STONE DISEASE | ||||||
| 09/17/2019 | Mallinckrodt Enterprises LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: ACUTE CARE | ||||||
| 09/11/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/09/2019 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Oncology | ||||||
| 08/28/2019 | Boston Scientific Corporation | GENERAL KIDNEY STONE DISEASE (Device) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: KIDNEY STONE DISEASE | ||||||
| 07/23/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: HYPERHYDROSIS | ||||||
| 07/18/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/11/2019 | Endo Pharmaceuticals Inc. | AVEED (Biological), EDEX, XIAFLEX | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: UROLOGY | ||||||
| 04/25/2019 | Photocure Inc | Cysview (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Oncology | ||||||
| 04/04/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: ONCOLOGY | ||||||
| 03/15/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 03/11/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Oncology | ||||||
| 03/08/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: UROLOGY | ||||||
| 02/12/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Oncology | ||||||
| 01/24/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: ONCOLOGY | ||||||
| 01/23/2019 | AbbVie, Inc. | Lupron Depot (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Endocrinology | ||||||
| 11/16/2018 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/06/2018 | Endo Pharmaceuticals Inc. | AVEED (Biological), TESTOPEL, XIAFLEX | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 427 | 492 | $108,496 | $28,972 |
| 2022 | 9 | 378 | 444 | $88,148 | $21,961 |
| 2021 | 9 | 353 | 413 | $105,880 | $25,744 |
| 2020 | 13 | 479 | 563 | $140,273 | $41,924 |
Total Patients
1,637
Total Services
1,912
Medicare Billing
$118,601
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 96 | $17,738 | $4,269 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 52 | 58 | $6,150 | $4,053 | 65.9% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 11 | $11,860 | $3,477 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 67 | 77 | $5,540 | $3,307 | 59.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 50 | $13,980 | $3,138 | 22.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 40 | 43 | $14,597 | $2,264 | 15.5% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 17 | 22 | $11,971 | $2,226 | 18.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 20 | 20 | $3,928 | $1,769 | 45.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 27 | 28 | $13,144 | $1,589 | 12.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 23 | 23 | $1,955 | $1,328 | 67.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,255 | $536.46 | 16.5% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 27 | 29 | $2,046 | $517.44 | 25.3% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 22 | 24 | $2,332 | $497.66 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 67 | 95 | $7,066 | $4,558 | 64.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 94 | $19,780 | $3,712 | 18.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 59 | 59 | $5,339 | $3,081 | 57.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 33 | 43 | $19,360 | $2,285 | 11.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 23 | 25 | $3,132 | $1,720 | 54.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 17 | 17 | $3,213 | $1,715 | 53.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 24 | $7,488 | $1,442 | 19.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 13 | 14 | $9,889 | $1,328 | 13.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 14 | 19 | $7,639 | $849.26 | 11.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 22 | 24 | $2,736 | $597.47 | 21.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 13 | $1,281 | $387.09 | 30.2% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 15 | 17 | $1,225 | $284.84 | 23.3% |
About Dr. Curtis Ross, D.O
Dr. Curtis Ross, D.O is a Urology healthcare provider based in Bangor, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2009. The National Provider Identifier (NPI) number assigned to this provider is 1063640555.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Curtis Ross, D.O has received a total of $1,917 in payments from pharmaceutical and medical device companies, with $21.00 received in 2024. These payments were reported across 62 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,796).
As a Medicare-enrolled provider, Ross has provided services to 1,637 Medicare beneficiaries, totaling 1,912 services with total Medicare billing of $118,601. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology, Urology
- Location Bangor, ME
- Active Since 06/23/2009
- Last Updated 02/03/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063640555
Products in Payments
- AquaBeam Robotic System (Device) $668.80
- GENERAL ERECTILE DYSFUNCTION (Device) $92.77
- XTANDI (Drug) $81.83
- Androgel (Drug) $67.93
- BOTOX (Biological) $66.72
- OFIRMEV (Drug) $65.30
- XIAFLEX (Biological) $63.32
- Xtandi (Drug) $59.81
- SpaceOAR (Device) $57.54
- AVEED (Biological) $52.14
- ELIGARD (Drug) $49.11
- ZYTIGA (Drug) $47.69
- Erleada (Drug) $44.81
- MYRBETRIQ (Drug) $44.32
- GENERAL KIDNEY STONE DISEASE (Device) $43.10
- PROVENGE (Drug) $39.23
- Cysview (Drug) $37.99
- Lupron Depot (Drug) $24.50
- ABIRATERONE ACETATE TABLETS (Drug) $24.42
- Nubeqa (Drug) $23.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.